Features and benefits

Product
description FEATURES BENEFITS
Red clover flower extract Titrated in Biochanin A, highly bioactive polyphenol
INCI NAME
Isopentyldiol (1) (and) Trifolium 3-in-1 action: Fights globally against pore enlargement causes for
Pratense (Clover) Flower Extract (2) - keratinization improvement an optimal result
- seboregulation
CAS - astringent action
2568-33-4 (1), 85085-25-2 (2)
Fast action results Reduces the appearance of pore size for a refined
EINECS and perfect skin in only 15 days!
459-270-7 (1), 285-356-7 (2)
Proven effective for men, Multi-usage (any gender, any age)
APPEARANCE women and young adults
Colourless to yellowish transparent
liquid

FORMULATION PoreFection Gel-Cream 15.330.01 C177

Miniporyl™ should be incorporated at
the end of the formulation process at INGREDIENTS INCI NAME %
a temperature below 40°C
A Deionized Water Water 82.80 Active
DOSAGE Dermofeel® PA-3 Sodium Phytate (and) Water (and) Alcohol 0.10 ingredients
0.5-2%
Glycerin Glycerin 2.00
OPTIMUM pH Lecigel™ Sodium Acrylates Copolymer (and) Lecithin 2.00
4-8 B Crodamol™ W Stearyl Heptanoate (and) Stearyl Caprylate 3.00

APPLICATIONS Schercemol™ SHS Isostearyl Hydroxystearate 3.00

- Combination and oily skin care C Granlux® AOX-GL Glycerin (and) Picea Abies Extract 1.00
- Acne prone skin care
- Uneven skin care
- Urban care
Verstatil® PC
D TR-1
Phenoxyethanol (and) Caprylyl Glycol
Nylon-6
1.10
1.00
MINIPORYL™
- Anti-pollution care SWT-7™ H Maltodextrin (and) Swertia Chirata Extract 1.00
- Sun face care
Progeline™ Glycerin (and) Water (and) Dextran (and) 1.00
- Cleansing products
- Men care
- Spa care Miniporyl™
Trifluoroacetyl Tripeptide-2
Isopentyldiol (and) Trifolium Pratense (Clover) 2.00 Picture-Perfect Pore
- Make up
- Teenager care
- Primer
Flower Extract
Minimizer
Red clover flower extract
titrated in Biochanin A
-
Primer-like high definition results:
Refines skin texture in only 15 days!
-
For all genders (women & men)
& all ages (young & old)
* Distributed in France by Lucas Meyer Cosmetics.
Litho Canada | 2016-02
This brochure is not intended for consumers and neither this brochure nor any extract thereof shall be used in order to commercialize products to consumers. No
drawing, photograph or other extract derived from this brochure shall be used by any person without our prior written approval. As well, no claim with respect to
the ingredient referred to in this brochure shall be made by any person without our prior written approval, even though the claim is set forth in this brochure. The
person using the ingredient referred to in this brochure in the formulation of finished products is solely responsible for ensuring that the use made of the ingredient,
the finished products marketed to consumers, their packaging, labeling and advertising materials and the claims made with respect to the finished products and the
ingredient comply with all applicable laws and regulations. We hereby disclaim any warranty of suitability of the ingredient referred to in this brochure for any purpose.
Any prospective user of the ingredient shall himself determine the suitability of the ingredient for his intended use and, as the case may be, obtain the required
regulatory approvals for the commercialization of his finished products.

LUCAS MEYER COSMETICS S.A.S. LUCAS MEYER COSMETICS CANADA INC.

ZA les Belles Fontaines Place de la Cité, Tour de la Cité

99 route de Versailles 2600 boul. Laurier, #900
91160 Champlan - France Québec (Québec) - G1V 4W2 Canada www.lucasmeyercosmetics.com
T: +33 (0)1 69 10 69 69 - F: +33 (0)1 69 10 69 70 T: +1 418 653-6888 - F: +1 418 653-6005 info@lucasmeyercosmetics.com
 REGULATION OF SEBUM PRODUCTION Evaluation of skin sebum variation

Titrated in biochanin a, Miniporyl™ reduces the appearance of 100

Up to -38%
Test protocol -17%*

conspicuous and unsightly enlarged pores with a complete

-30%*
80
- 2 groups of 20 men & women with oily or combination skin (18 to 55 years old)

Sebum rate
(% vs. D0)
60
- 2x/D application of a cream with 2% Miniporyl™ for one group vs. a placebo for the
mechanism of action to rapidly recover a refined high definition skin. other group, during 30 days 40

- Seboregulation measurement at D0, D15 and D30 with Sebumeter® 20

- Self assessment 0
D15 D30
* p<0.001
Red clover flower (Trifolium Pratense)
BIOCHANIN A FROM RED CLOVER The inhibition of 5a-reductase induces a decrease in sebum production in the
sebaceous glands. The oily flow is reduced and a lower amount circulates in the pore Placebo Miniporyl™ 2%

EXTRACT channel, preventing its enlargement.

Native to Europe, Western Asia and Northwest Africa, red clover is also planted and
naturalized in several other regions. Globally available in the wild, red clover is still
traditionally used in many countries for its purifying and rebalancing properties. REDUCTION IN PORE SIZE Evaluation of visible pore number variation

Up to -80%
Extracted from red clover flower, Miniporyl™ is a plant-derived pore minimizer Test protocol 2000

Number of visible pores

-12%*

(nose and cheek aera)

-16%*
designed to rebalance skin conditions responsible for pore enlargement. With a titrated - 2 groups of 20 men & women (18 to 55 years old) 1500
content of bioactive polyphenol Biochanin A (≥ 0.4%), Miniporyl™ acts effectively and - 2x/D application of a cream with 2% Miniporyl™ for one group vs. a placebo for the
1000
simultaneously on different biological targets to refine the skin with a fast action. other group, during 30 days
- Quantification of conspicuous pores on cheeks and nose by image analysis 500
As a skin treatment, Miniporyl™ has a complementary effect compared to pore filling
- Self-assessment
silicone-based primer, which has only a short-lasting immediate physical action. 0
D0 D15 D30
Miniporyl™ * p<0.05
Young adult
Quantification of differentiation Miniporyl™ 2%

Involucrin
markers by immunofluorescence

Filaggrin Keratin 10
3-IN-1 PORE SHRINKING ACTION
Miniporyl™ globally acts on the 3 main skin mechanisms behind excessive pore dilation
in order to tighten them up and to reach a flawless and even complexion. Self assessment

Skin is smooth 95%

Untreated D4 Keratinization improvement D0 D30

Skin is rebalanced
Skin seems less oily
95%
95%
Skin looks healthy 95%
Pore enlargement is linked to an incomplete keratinocyte differentiation, characterized Woman skin
Skin is radiant 90%
by the retention of nuclei in corneocytes that prevents normal desquamation process. Skin is purified 90%
Accumulated at the surface of the pore, these skin barrier dead cells clog the orifice Skin texture is refined 84%

leading to a mechanical pore dilation. Pore size is reduced 84%

Skin is matified 84%
Complexion is even 79%
Miniporyl™ 0.1% D4
The increase in the synthesis of markers such as filaggrin, involucrin and keratin Blackdot appearance
74%
10 confirms the normalization of the differentiation process of keratinocytes into is reduced
Positive opinion (%)
Evaluation of sebum accumulation in sebocytes nucleus free corneocytes to preserve a healthy skin barrier and eliminate cell debris.

60 D0 D30
Lipid synthesis inhibition
(% vs. positive control)

Seborrhea regulation
48%
Man
40
28%
Pore enlargement is observed in all skin types but is amplified with oily skin and acne
20
prone skin since the pore has to expand to accommodate the outpouring of excess
6%
sebum.
0
0.0025% 0.05% 0.1%
Miniporyl™
Miniporyl TM The reduction in sebum accumulation in sebocytes, due to the inhibition of
5a-reductase, prevents the opening of pores.

D0 D30
Evaluation of contraction properties
Astringent action
Filbroblast
culture

Collagen
lattices
+25% Loss of skin firmness and tonicity induces tissue relaxation and collapse of pore wall,
which lead to a larger pore opening. Miniporyl™ visibly reduces the appearance of pores to
The increase in the skin’s contraction properties maintains optimal pore structure recover a “porefect” skin texture at any age!
Untreated Miniporyl™ 2% and close pores.
 REGULATION OF SEBUM PRODUCTION Evaluation of skin sebum variation

Titrated in biochanin a, Miniporyl™ reduces the appearance of 100

Up to -38%
Test protocol -17%*

conspicuous and unsightly enlarged pores with a complete

-30%*
80
- 2 groups of 20 men & women with oily or combination skin (18 to 55 years old)

Sebum rate
(% vs. D0)
60
- 2x/D application of a cream with 2% Miniporyl™ for one group vs. a placebo for the
mechanism of action to rapidly recover a refined high definition skin. other group, during 30 days 40

- Seboregulation measurement at D0, D15 and D30 with Sebumeter® 20

- Self assessment 0
D15 D30
* p<0.001
Red clover flower (Trifolium Pratense)
BIOCHANIN A FROM RED CLOVER The inhibition of 5a-reductase induces a decrease in sebum production in the
sebaceous glands. The oily flow is reduced and a lower amount circulates in the pore Placebo Miniporyl™ 2%

EXTRACT channel, preventing its enlargement.

Native to Europe, Western Asia and Northwest Africa, red clover is also planted and
naturalized in several other regions. Globally available in the wild, red clover is still
traditionally used in many countries for its purifying and rebalancing properties. REDUCTION IN PORE SIZE Evaluation of visible pore number variation

Up to -80%
Extracted from red clover flower, Miniporyl™ is a plant-derived pore minimizer Test protocol 2000

Number of visible pores

-12%*

(nose and cheek aera)

-16%*
designed to rebalance skin conditions responsible for pore enlargement. With a titrated - 2 groups of 20 men & women (18 to 55 years old) 1500
content of bioactive polyphenol Biochanin A (≥ 0.4%), Miniporyl™ acts effectively and - 2x/D application of a cream with 2% Miniporyl™ for one group vs. a placebo for the
1000
simultaneously on different biological targets to refine the skin with a fast action. other group, during 30 days
- Quantification of conspicuous pores on cheeks and nose by image analysis 500
As a skin treatment, Miniporyl™ has a complementary effect compared to pore filling
- Self-assessment
silicone-based primer, which has only a short-lasting immediate physical action. 0
D0 D15 D30
Miniporyl™ * p<0.05
Young adult
Quantification of differentiation Miniporyl™ 2%

Involucrin
markers by immunofluorescence

Filaggrin Keratin 10
3-IN-1 PORE SHRINKING ACTION
Miniporyl™ globally acts on the 3 main skin mechanisms behind excessive pore dilation
in order to tighten them up and to reach a flawless and even complexion. Self assessment

Skin is smooth 95%

Untreated D4 Keratinization improvement D0 D30

Skin is rebalanced
Skin seems less oily
95%
95%
Skin looks healthy 95%
Pore enlargement is linked to an incomplete keratinocyte differentiation, characterized Woman skin
Skin is radiant 90%
by the retention of nuclei in corneocytes that prevents normal desquamation process. Skin is purified 90%
Accumulated at the surface of the pore, these skin barrier dead cells clog the orifice Skin texture is refined 84%

leading to a mechanical pore dilation. Pore size is reduced 84%

Skin is matified 84%
Complexion is even 79%
Miniporyl™ 0.1% D4
The increase in the synthesis of markers such as filaggrin, involucrin and keratin Blackdot appearance
74%
10 confirms the normalization of the differentiation process of keratinocytes into is reduced
Positive opinion (%)
Evaluation of sebum accumulation in sebocytes nucleus free corneocytes to preserve a healthy skin barrier and eliminate cell debris.

60 D0 D30
Lipid synthesis inhibition
(% vs. positive control)

Seborrhea regulation
48%
Man
40
28%
Pore enlargement is observed in all skin types but is amplified with oily skin and acne
20
prone skin since the pore has to expand to accommodate the outpouring of excess
6%
sebum.
0
0.0025% 0.05% 0.1%
Miniporyl™
Miniporyl TM The reduction in sebum accumulation in sebocytes, due to the inhibition of
5a-reductase, prevents the opening of pores.

D0 D30
Evaluation of contraction properties
Astringent action
Filbroblast
culture

Collagen
lattices
+25% Loss of skin firmness and tonicity induces tissue relaxation and collapse of pore wall,
which lead to a larger pore opening. Miniporyl™ visibly reduces the appearance of pores to
The increase in the skin’s contraction properties maintains optimal pore structure recover a “porefect” skin texture at any age!
Untreated Miniporyl™ 2% and close pores.
 Features and benefits
Product
description FEATURES BENEFITS
Red clover flower extract Titrated in Biochanin A, highly bioactive polyphenol
INCI NAME
Isopentyldiol (1) (and) Trifolium 3-in-1 action: Fights globally against pore enlargement causes for
Pratense (Clover) Flower Extract (2) - keratinization improvement an optimal result
- seboregulation
CAS - astringent action
2568-33-4 (1), 85085-25-2 (2)
Fast action results Reduces the appearance of pore size for a refined
EINECS and perfect skin in only 15 days!
459-270-7 (1), 285-356-7 (2)
Proven effective for men, Multi-usage (any gender, any age)
APPEARANCE women and young adults
Colourless to yellowish transparent
liquid

FORMULATION PoreFection Gel-Cream 15.330.01 C177

Miniporyl™ should be incorporated at
the end of the formulation process at INGREDIENTS INCI NAME %
a temperature below 40°C
A Deionized Water Water 82.80 Active
DOSAGE Dermofeel® PA-3 Sodium Phytate (and) Water (and) Alcohol 0.10 ingredients
0.5-2%
Glycerin Glycerin 2.00
OPTIMUM pH Lecigel™ Sodium Acrylates Copolymer (and) Lecithin 2.00
4-8 B Crodamol™ W Stearyl Heptanoate (and) Stearyl Caprylate 3.00

APPLICATIONS Schercemol™ SHS Isostearyl Hydroxystearate 3.00

- Combination and oily skin care C Granlux® AOX-GL Glycerin (and) Picea Abies Extract 1.00
- Acne prone skin care
- Uneven skin care
- Urban care
Verstatil® PC
D TR-1
Phenoxyethanol (and) Caprylyl Glycol
Nylon-6
1.10
1.00
MINIPORYL™
- Anti-pollution care SWT-7™ H Maltodextrin (and) Swertia Chirata Extract 1.00
- Sun face care
Progeline™ Glycerin (and) Water (and) Dextran (and) 1.00
- Cleansing products
- Men care
- Spa care Miniporyl™
Trifluoroacetyl Tripeptide-2
Isopentyldiol (and) Trifolium Pratense (Clover) 2.00 Picture-Perfect Pore
- Make up
- Teenager care
- Primer
Flower Extract
Minimizer
Red clover flower extract
titrated in Biochanin A
-
Primer-like high definition results:
Refines skin texture in only 15 days!
-
For all genders (women & men)
& all ages (young & old)
* Distributed in France by Lucas Meyer Cosmetics.
Litho Canada | 2016-02
This brochure is not intended for consumers and neither this brochure nor any extract thereof shall be used in order to commercialize products to consumers. No
drawing, photograph or other extract derived from this brochure shall be used by any person without our prior written approval. As well, no claim with respect to
the ingredient referred to in this brochure shall be made by any person without our prior written approval, even though the claim is set forth in this brochure. The
person using the ingredient referred to in this brochure in the formulation of finished products is solely responsible for ensuring that the use made of the ingredient,
the finished products marketed to consumers, their packaging, labeling and advertising materials and the claims made with respect to the finished products and the
ingredient comply with all applicable laws and regulations. We hereby disclaim any warranty of suitability of the ingredient referred to in this brochure for any purpose.
Any prospective user of the ingredient shall himself determine the suitability of the ingredient for his intended use and, as the case may be, obtain the required
regulatory approvals for the commercialization of his finished products.

LUCAS MEYER COSMETICS S.A.S. LUCAS MEYER COSMETICS CANADA INC.

ZA les Belles Fontaines Place de la Cité, Tour de la Cité

99 route de Versailles 2600 boul. Laurier, #900
91160 Champlan - France Québec (Québec) - G1V 4W2 Canada www.lucasmeyercosmetics.com
T: +33 (0)1 69 10 69 69 - F: +33 (0)1 69 10 69 70 T: +1 418 653-6888 - F: +1 418 653-6005 info@lucasmeyercosmetics.com